Vialwirebiotech, curated
July 2, 2026, 12:09 PM
June 24, 2026
- 12:00 PM · BioWorld12:00 PMLilly’s GLP-1 windfall fuels M&A ‘land grab’ across 10 deals, $25B — BioWorld
- 12:00 PM · BioWorld12:00 PMAntares, Novartis pursuing undruggable cancer targets in $1.9B deal — BioWorld
- 12:00 PM · BioWorld12:00 PMTissium secures €60M to advance sutureless tissue repair platform — BioWorld
- 12:00 PM · BioWorld12:00 PMLilly taps Abbisko for $1.9B discovery deal — BioWorld
- 11:46 AM · Drug Discovery World11:46 AMLonza and InduPro to collaborate on next-gen ADC therapies — Drug Discovery World
- 9:00 AM · PharmaVoice9:00 AMRecent pharma exec shake-ups signal strategic shifts — PharmaVoice
- 8:12 AM · BioPharma Dive8:12 AMSangamo holds a bankruptcy sale; VCs back a China-linked Beam competitor — BioPharma Dive
- 8:00 AM · FT — Pharmaceuticals8:00 AMStripe and Anthropic invest in combating respiratory diseases — FT — Pharmaceuticals
- 7:00 AM · BioPharma Dive7:00 AMOllin refuels with $330M to back pivotal tests of Vabysmo challenger — BioPharma Dive
- 6:34 AM · Pharmaceutical Technology6:34 AMŌURA and Lilly join forces to harmonise drug-wearable obesity care — Pharmaceutical Technology
- 5:53 AM · Drug Discovery World5:53 AMNura Bio raises $73.8m, advances pipeline of SARM1 inhibitors — Drug Discovery World
- 4:31 AM · Drug Discovery World4:31 AMTRIMTECH raises $47m for protein degradation portfolio — Drug Discovery World
- 4:10 AM · Pharmaceutical Technology4:10 AMHaisco and Nuvectis sign licensing deal for two drugs — Pharmaceutical Technology
June 23, 2026
- 5:00 PM · MIT Technology Review5:00 PMEngineered “mini livers” could be injected as an alternative to transplantation — MIT Technology Review
- 5:00 PM · MIT Technology Review5:00 PMA breath test could diagnose pneumonia in minutes — MIT Technology Review
- 12:00 PM · BioWorld12:00 PMChina’s Micot targets HK$1.2B IPO to advance metabolic portfolio — BioWorld
- 12:00 PM · BioWorld12:00 PMChina approves first CAR T for solid tumors — BioWorld
- 12:00 PM · BioWorld12:00 PMPfizer ADC, from Seagen M&A, fails in phase III NSCLC trial — BioWorld
- 12:00 PM · BioWorld12:00 PMCynata’s Cymerus flops in osteoarthritis, GVHD — BioWorld
- 12:00 PM · BioWorld12:00 PMUS FDA approves 24 drugs in May in busiest month of 2026 — BioWorld
- 12:00 PM · BioWorld12:00 PMSK Biopharm taps Insilico in $2.5B AI CNS drug discovery deal — BioWorld
- 12:00 PM · BioWorld12:00 PMJ-Pharma drives first cancer LAT1 to phase III study with FDA nod — BioWorld
- 11:30 AM · Drug Discovery World11:30 AMCellares extends funding for cell therapy manufacturing — Drug Discovery World
- 10:59 AM · Drug Discovery World10:59 AMEC approves metastatic colorectal cancer combination regimen — Drug Discovery World
- 9:26 AM · Pharmaceutical Technology9:26 AMFDA changes rare disease tune again as it clears path for Regenxbio’s gene therapy — Pharmaceutical Technology
- 9:00 AM · BioWorld9:00 AMZydus Lifesciences discloses new triglyceride-lowering agents — BioWorld
- 9:00 AM · BioWorld9:00 AMAnhorn Medicines gains IND clearance for neuroprotectant AH-008 — BioWorld
- 9:00 AM · BioWorld9:00 AMMatricelf studies neural tissue implant for spinal cord injury — BioWorld
- 9:00 AM · BioWorld9:00 AMLys Therapeutics advances LYS-241 — BioWorld
- 9:00 AM · BioWorld9:00 AMK2 nabs two Antengene bispecific TCEs in $2B license, option deal — BioWorld
- 7:30 AM · STAT News
- 5:51 AM · Pharmaceutical Technology5:51 AMGenprex’s Reqorsa combo secures Canadian patent for lung cancer — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMKither completes Phase I trial of inhaled peptide therapy — Drug Discovery World
- 5:00 AM · Wired — Science5:00 AM3 People Have Gotten Cancer-Detecting Implants in Their Brains — Wired — Science
- 4:53 AM · Pharmaceutical Technology4:53 AMUS patent infringement investigation targets German drug price control measures — Pharmaceutical Technology
- 12:00 AM · FT — Pharmaceuticals12:00 AMEli Lilly deploys weight-loss cash on ‘App Store’ for scientists — FT — Pharmaceuticals
June 22, 2026
- 4:42 PM · SCMP — Tech4:42 PMUS-China rare earth clash 2.0? Fragile truce tested as tit-for-tat moves return — SCMP — Tech